Intra-amygdala injections of neuropeptide S block fear-potentiated startle.
Fendt
Markus
M
Novartis Institutes of BioMedical Research, Neuropsychiatry, GPCR Expertise Program, Basel, Switzerland. Electronic address: markus.fendt@novartis.com.
Imobersteg
Stefan
S
Novartis Institutes of BioMedical Research, Neuropsychiatry, GPCR Expertise Program, Basel, Switzerland.
Bürki
Hugo
H
Novartis Institutes of BioMedical Research, Neuropsychiatry, GPCR Expertise Program, Basel, Switzerland.
McAllister
Kevin H
KH
Novartis Institutes of BioMedical Research, Neuropsychiatry, GPCR Expertise Program, Basel, Switzerland.
Sailer
Andreas W
AW
Novartis Institutes of BioMedical Research, Developmental and Molecular Pathways, GPCR Expertise Program, Basel, Switzerland.
D000679:Amygdala / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D003214:Conditioning, Classical / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005239:Fear / Q000187:drug effects*; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009479:Neuropeptides / Q000008:administration & dosage*; D013216:Reflex, Startle / Q000187:drug effects* / Q000502:physiology
D009479:Neuropeptides; C539972:neuropeptide S, mouse